Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 06, 2022

SELL
$48.09 - $57.79 $310,901 - $373,612
-6,465 Closed
0 $0
Q3 2021

Oct 12, 2021

SELL
$56.91 - $67.81 $78,820 - $93,916
-1,385 Reduced 17.64%
6,465 $387,000
Q1 2020

Apr 21, 2020

BUY
$32.82 - $81.13 $37,808 - $93,461
1,152 Added 17.2%
7,850 $398,000
Q2 2019

Jul 15, 2019

BUY
$53.69 - $65.47 $429 - $523
8 Added 0.12%
6,698 $392,000
Q1 2019

Apr 02, 2019

SELL
$44.53 - $58.9 $121,344 - $160,502
-2,725 Reduced 28.94%
6,690 $380,000
Q4 2018

Jan 11, 2019

BUY
$47.64 - $71.26 $5,859 - $8,764
123 Added 1.32%
9,415 $467,000
Q3 2018

Oct 16, 2018

BUY
$52.03 - $71.41 $483,462 - $663,541
9,292 New
9,292 $660,000

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track First Hawaiian Bank Portfolio

Follow First Hawaiian Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

News

Stay updated on First Hawaiian Bank with notifications on news.